Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients

Stopped Study design revised and to be found under new NCT06456593 ABX464-202

Conditions

• Crohn Disease

Interventions

• DRUG: ABX464
• DRUG: Placebo

Sponsor

Abivax S.A.